Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.725 USD | +1.30% | +0.56% | +22.85% |
Feb. 28 | Transcript : Standard BioTools Inc., Q4 2023 Earnings Call, Feb 28, 2024 | |
Feb. 28 | Standard BioTools Inc. Provides Revenue Guidance for the Full Year 2024 | CI |
Evolution of the average Target Price on Standard BioTools Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Standard BioTools Inc.
KeyBanc Capital Markets | |
BTIG | |
UBS |
EPS Revisions
- Stock
- Equities
- Stock Standard BioTools Inc. - Nasdaq
- Consensus Standard BioTools Inc.